Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre Study Evaluating Creos™ Xenogain Bone Graft Substitute in Horizontal Ridge Augmentation in the Premolar and Molar Region of the Mandible

NCT03028922 is registered in ClinicalTrials.gov with Nobel Biocare as lead sponsor.

NCT NCT03028922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03028922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre Study Evaluating Creos™ Xenogain Bone Graft Substitute in Horizontal Ridge Augmentation in the Premolar and Molar Region of the Mandible
Lead sponsor
Nobel Biocare
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2016
Completion date
June 30, 2020
Enrollment
42 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

horizontal bone augmentation